U.S. Markets close in 2 hrs 25 mins

Supernus Pharmaceuticals, Inc. (SUPN)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
43.25+0.50 (+1.17%)
As of 1:34PM EDT. Market open.
People also watch
SCMPPCRXOMERIRWDHZNP
Full screen
Previous Close42.75
Open42.60
Bid43.05 x 800
Ask43.10 x 100
Day's Range42.60 - 43.50
52 Week Range17.25 - 43.50
Volume313,295
Avg. Volume606,309
Market Cap2.17B
Beta2.21
PE Ratio (TTM)23.27
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Forbes23 hours ago

    Todd Hagopian's Top 2 Mental Health Biotech Stocks

    The mental health biotech sub-sector includes companies developing drugs for ADHD, depression, bipolar disorder, schizophrenia, migraines, alzheimer's, and other central nervous system conditions. Due to growing public awareness, Todd Hagopian believes these stocks are reaching a tipping point.

  • Capital Cube3 days ago

    ETFs with exposure to Supernus Pharmaceuticals, Inc. : June 19, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Supernus Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to SUPN-US. Comparing the performance and risk of Supernus Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Supernus Pharmaceuticals, Inc. :SUPN-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017
    Capital Cube6 days ago

    Supernus Pharmaceuticals, Inc. :SUPN-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017

    Categories: Yahoo FinanceGet free summary analysis Supernus Pharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Supernus Pharmaceuticals, Inc. – United Therapeutics Corporation, Zogenix, Inc., Alcobra Ltd., Bristol-Myers Squibb Company, Eli Lilly and Company, Shire PLC Sponsored ADR, Johnson & Johnson and Abbott Laboratories ... Read more (Read more...)